Heartland Advisors Inc Haemonetics Corp Transaction History

Heartland Advisors Inc

$1.87 Billion
Q3 2024

A detailed history of Heartland Advisors Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Heartland Advisors Inc holds 141,098 shares of HAE stock, worth $10.6 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

141,098

Previous 172,701 18.3%

Holding current value

$10.6 Million

Previous $14.3 Million 20.63%

% of portfolio

0.61%

Previous 0.82%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$72.45 - $91.58 $2.29 Million - $2.89 Million	-31,603 Reduced 18.3%	141,098 $11.3 Million
Q2 2024 Aug 08, 2024	SELL	$81.24 - $97.37 $3.77 Million - $4.51 Million	-46,364 Reduced 21.16%	172,701 $14.3 Million
Q1 2024 May 07, 2024	SELL	$71.24 - $85.35 $187,503 - $224,641	-2,632 Reduced 1.19%	219,065 $18.7 Million
Q4 2023 Feb 08, 2024	SELL	$80.59 - $92.61 $2.8 Million - $3.22 Million	-34,717 Reduced 13.54%	221,697 $19 Million
Q3 2023 Nov 08, 2023	SELL	$82.56 - $93.49 $2.17 Million - $2.45 Million	-26,253 Reduced 9.29%	256,414 $23 Million
Q2 2023 Aug 10, 2023	SELL	$80.84 - $89.45 $3.7 Million - $4.1 Million	-45,824 Reduced 13.95%	282,667 $24.1 Million
Q1 2023 May 11, 2023	SELL	$72.75 - $90.6 $1.09 Million - $1.36 Million	-15,014 Reduced 4.37%	328,491 $27.2 Million
Q4 2022 Feb 08, 2023	SELL	$73.85 - $86.14 $5.06 Million - $5.9 Million	-68,541 Reduced 16.63%	343,505 $27 Million
Q3 2022 Nov 10, 2022	SELL	$63.3 - $78.66 $759,600 - $943,920	-12,000 Reduced 2.83%	412,046 $30.5 Million
Q2 2022 Aug 12, 2022	SELL	$49.27 - $66.08 $773,539 - $1.04 Million	-15,700 Reduced 3.57%	424,046 $27.6 Million
Q1 2022 May 12, 2022	BUY	$43.77 - $63.22 $1.47 Million - $2.12 Million	33,554 Added 8.26%	439,746 $27.8 Million
Q4 2021 Feb 09, 2022	BUY	$49.55 - $74.59 $2.56 Million - $3.86 Million	51,760 Added 14.6%	406,192 $21.5 Million
Q3 2021 Nov 09, 2021	BUY	$57.6 - $70.59 $310,464 - $380,480	5,390 Added 1.54%	354,432 $25 Million
Q2 2021 Aug 11, 2021	BUY	$51.81 - $118.56 $18.1 Million - $41.4 Million	349,042 New	349,042 $23.3 Million
Q4 2017 Feb 02, 2018	SELL	$44.96 - $58.99 $7.44 Million - $9.76 Million	-165,494 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$40.38 - $44.87 $6.68 Million - $7.43 Million	165,494	165,494 $7.43 Million

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Advisors Inc with notifications on news.

Account

Heartland Advisors Inc Haemonetics Corp Transaction History